Accuracy of real-time polymerase chain reaction for toxoplasma gondii in amniotic fluid

Obstetrics and Gynecology

Volumn 115, Issue 4, 2010, Pages 727-733

  Wallon, Martine ^a   Franck, Jacqueline ^b   Thulliez, Philippe ^b   Huissoud, Cyril ^b   Peyron, François ^b   Garcia Meric, Patricia ^b   Kieffer, François ^b  

^a CROIX ROUSSE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE; SPIRAMYCIN; SULFONAMIDE;

AMNIOCENTESIS; AMNION FLUID; AMNION FLUID ANALYSIS; ARTICLE; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONGENITAL TOXOPLASMOSIS; DIAGNOSTIC ACCURACY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; MATERNAL INFECTION; PARASITE IDENTIFICATION; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

AMNIOCENTESIS; AMNIOTIC FLUID; DNA, PROTOZOAN; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 77949903448     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181d57b09     Document Type: Article

References (26)

1. Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J 2008;27:27-32.
2. Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, et al, Long-term Ocular Prognosis in 327 Children with Congenital Toxoplasmosis Pediatrics. 2004;113:1567-1572
3. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappa-lainen M, Pinon JM, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Obstet Gynecol 1999; 180:410-415
4. Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 2005;94: 1721-1731
5. SYROCOT (Systematic Review on Congenital Toxoplasmo-sis) study group, Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmo-sis: a meta-analysis of individual patients' data. Lancet 2007; 369:115-122
6. Leroy V, Raeber PA, Petersen E, Salmi LR, Kaminski M, Villena I, et al. National public health policies and routine programs to prevent congenital toxoplasmosis. Available at: http://eurotoxo. isped.u-bordeaux2.fr/WWW-PUBLIC/ DOC/EUROTOXO- R1-P3-European-national-policies-Dec2005.pdf. Retrieved August 17, 2009.
7. Berger F, Goulet V, Le Strat Y, Desenclos JC. Toxoplasmosis in pregnant women in France: trends in seroprevalence and incidence, and associated factors, 1995-2003 [in French]. Bull Epidemiol Hebd 2008;14-5:117-121
8. Jones JL, Kruszon-Moran D, Wilson M. Toxoplasma gondii infection in the United States, 1999-2000. Emerg Infect Dis 2003;9:1371-1374
9. Thalib L, Gras L, Romand S, Prusa A, Bessieres MH, Petersen E, et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG 2005;112: 567-574
10. Leroy V, Harambat J, Perez P, Rudin C, Petersen E, for the Eurotoxo Group (Panel 3). Performances of tests involved in screening and diagnosing of acute maternal toxoplasmosis during pregnancy and congenital infection. A systematic review, 1985-2005. Available at: http://eurotoxo.isped.u-bordeaux2.fr/ WWW-PUBLIC/DOC/EUROTOXO-R5-P3-Performances- diag-tools-April2006.pdf. Retrieved August 17, 2009.
11. Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 2001;97:296-300.
12. Costa JM, Pautas C, Ernault P, Foulet F, Cordonnier C, Bretagne S. Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. J Clin Microbiol 2000;38:2929-2932
13. Homan WL, Vercammen M, De Braekeleer J, Verschueren H. Identification of a 200-to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol 2000;30:69-75.
14. Reischl U, Bretagne S, Krüger D, Ernault P, Costa JM. Comparison of two DNA targets for the diagnosis of Toxoplas-mosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis 2003;3:7.
15. Filisetti D, Gorcii M, Pernot-Marino E, Villard O, Candolfi E. Diagnosis of congenital toxoplasmosis: comparison of targets for detection of Toxoplasma gondii by PCR. J Clin Microbiol 2003;41:4826-4828
16. Kasper DC, Sadeghi K, Prusa AR, Reischer GH, Kratochwill K, Fö rster-Waldl E, et al. Quantitative real-time polymerase chain reaction for the accurate detection of Toxoplasma gondii in amniotic fluid. Diagn Microbiol Infect Dis 2009;63:10-15
17. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996;15:799-805.
18. Bastien P, Procop GW, Reischl U. Quantitative real-time PCR is not more sensitive than "conventional PCR." J Clin Micro-biol 2008;46:1897-1900
19. Costa JM, Ernault P, Gautier E, Bretagne S. Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes. Prenat Diagn 2001;21:85-88
20. Ordinaire I, Simon A, Fréalle E, Soula F, Valat AS, Rouland V, et al. Real-time quantitative PCR for toxoplasmosis diagnosis [in French]. Ann Biol Clin (Paris) 2005;63:67-73 French.
21. Edvinsson B, Lappalainen M, Evengård B, ESCMID Study Group for Toxoplasmosis. Real-time PCR targeting a 529-bp repeat element for diagnosis of toxoplasmosis. Clin Microbiol Infect 2006;12:131-136
22. Nagy B, Bán Z, Beke A, Nagy GR, Lázár L, Papp C, et al. Detection of Toxoplasma gondii from amniotic fluid, a comparison of four different molecular biological methods. Clin Chim Acta 2006;368:131-137
23. Cassaing S, Bessières MH, Berry A, Berrebi A, Fabre R, Magnaval JF. Comparison between two amplification sets for molecular diagnosis of toxoplasmosis by real-time PCR [published erratum appears in J Clin Microbiol 2006;44:4295]. J Clin Microbiol 2006;44:720-724
24. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999;353:1829-1833
25. Romand S, Chosson M, Franck J, Wallon M, Kieffer F, Kaiser K, et al. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol 2004;190: 797-802.
26. Zalud I, Janas S. Risks of third-trimester amniocentesis. J Reprod Med 2008;53:45-48